Loss of p53 compensates for alpha v-integrin function in retinal neovascularization (Q45714093)

From Wikidata

Revision as of 05:58, 15 February 2024 by KrBot (talk | contribs) (‎Set a claim value: title (P1476): Loss of p53 compensates for alpha v-integrin function in retinal neovascularization)

(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Jump to navigation Jump to search

scientific article published on 20 February 2002

Language	Label	Description	Also known as
English	Loss of p53 compensates for alpha v-integrin function in retinal neovascularization	scientific article published on 20 February 2002

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Loss of p53 compensates for alpha v-integrin function in retinal neovascularization (English)

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

neovascularization

1 reference

based on heuristic

inferred from title

Staffan Strömblad

object named as

Staffan Strömblad

1

0 references

Chandra L Theesfeld

4

object named as

Chandra Theesfeld

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

author name string

Arun Fotedar

2

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Howard Brickner

3

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Edith Aguilar de Diaz

5

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Martin Friedlander

6

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

David A Cheresh

7

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

language of work or name

0 references

publication date

20 February 2002

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

277

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

16

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

13371-13374

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Requirement of vascular integrin alpha v beta 3 for angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Extensive vasculogenesis, angiogenesis, and organogenesis precede lethality in mice lacking all alpha v integrins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Tumor spectrum analysis in p53-mutant mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Arg-Gly-Asp constrained within cyclic pentapeptides. Strong and selective inhibitors of cell adhesion to vitronectin and laminin fragment P1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Angiogenesis in cancer, vascular, rheumatoid and other disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Cell cycle inhibition by the anti-angiogenic agent TNP-470 is mediated by p53 and p21WAF1/CIP1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Suppression of p53 function in normal human mammary epithelial cells increases sensitivity to extracellular matrix-induced apoptosis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Integrin alphavbeta3 requirement for sustained mitogen-activated protein kinase activity during angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Definition of Two Angiogenic Pathways by Distinct alpha(v) Integrins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Cell adhesion and angiogenesis

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Enhanced pathological angiogenesis in mice lacking β3 integrin or β3 and β5 integrins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Effect of p21waf1/cip1 transgene on radiation induced apoptosis in T cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Essential role for caspase-8 in transcription-independent apoptosis triggered by p53

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1

1 reference

https://api.crossref.org/works/10.1074%2FJBC.C200044200

21 January 2018

Identifiers

10.1074/JBC.C200044200

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

15 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45714093&oldid=2077710271"